Elle Investments
Contributor since: 2018
Company: Elle investments
Articles
AcelRx Pharmaceuticals: Finally Light At The End Of The Tunnel
ObsEva Has A Promising Candidate For An Unmet Need - Behind The Idea
ObsEva Has A Promising Candidate For An Unmet Need
Advanced Micro Devices: A Solid Buy
Vericel Corporation: A Must-Have Biotech Post-COVID-19 Sell-Off - Behind The Idea
Vericel Corporation: A Must-Have Biotech Post-COVID-19 Sell-Off
Xinyuan Real Estate Co.: Q4 2019 Recap
Omeros Corporation: The Thesis Was Playing Out Before COVID-19 Hit
American Superconductor Corporation: A Great Short-Term And Long-Term Opportunity - Behind The Idea
American Superconductor Corporation: A Great Short-Term And Long-Term Opportunity
Fennec Pharmaceuticals: Market Fatigue Due To A Lack Of Catalysts Has Created A Mispricing
Fennec Pharmaceuticals: Market Fatigue Due To A Lack Of Catalysts Has Created A Mispricing - Behind The Idea
AstroNova: Even With The Recent Decline, It's Not A Clear Buying Opportunity
Spectrum Pharmaceuticals: Stock Price Drop Vs. Disappointing Clinical Data Provides Good Upside
Galectin Therapeutics: An Even Better Buy As It Hits 52-Week Lows
Akebia Therapeutics: No Change To The Thesis, And The Lower Entry Point Improves The Bet
Xinyuan Real Estate Co.: The 10% Dividend Yield Makes For An Even Better Entry Point
BeyondSpring: The Drop From The Capital Raise Offers A Good Entry Point
VOXX International Corporation: The Net Assets Per Share Limit The Downside
Spectrum Pharmaceuticals: Great Asset, Great Liquidity, Low Price
Behind The Idea: Spectrum Pharma - Great Asset
Omeros: The Commercial Prospects Remain Bright
Akebia Therapeutics: Still A Strong Buy After The 50% Decline
Tailored Brands: Down A Lot Recently, But Holding Steady After 1QFY19 Earnings
Puma Biotechnology: Nerlynx Peak Sales Estimates Have Come Down, But The Intense Selling Still Makes This A Buy
McDermott International: Small Short-Term Spending Increases Should Not Overshadow The Long-Term Value Creation
Puma Biotechnology: Investors Didn't Like The EU/Africa Partnership Terms, But The Risk/Reward Is Attractive
Akebia Therapeutics: Still A Buy Post-Merger
Tailored Brands: A Continued Overreaction You Can Exploit
Townsquare Media: The Ups And Downs Belie A Steady Business Underneath
McDermott International: Righting The Ship
Chesapeake Energy Corporation: The Thesis Is Playing Out